Technological Discontinuities and the Comparative Strategic Value of New Capabilites: Evidence from the Comparison of Small- and Large-Molecule Targeted Anti-Cancer Drug Discovery
Traditional creative destruction theories distinguish disruptions as competence-destroying or competence-enhancing to incumbents’ capabilities, with the former case resulting in incumbents’ loss of competitive advantage in in-house R&D performance (even if complementary assets aid in retaining final market share). In this paper, I propose that attention to the extent of competence destruction is necessary but not sufficient for analyses of competitive advantage in R&D through a technological discontinuity. A full analysis requires the comparison of the value added and ease of access (i.e., strategic value) of all capabilities, old and new. In other words, an analysis of competition during a transition requires assessment not only of how many of the old capabilities were lost but also what it takes to acquire the new ones. I find evidence for this proposition in qualitative and quantitative data from the transition of anti-cancer drug discovery from standard chemotherapy to targeted therapies. Among targeted therapies, I compare two variants, small- vs. large-molecule drugs, which though equally competence-destroying to chemotherapy-based drug discovery, differ in that large-molecule drugs require one more new capability: expertise in biopharmaceutical technology. By tracing the origin and evolution of biopharmaceutical technology, as well as its comparative value added, I can show a contrast in results: incumbents led in small-molecule targeted drug discovery; but they fell behind biopharmaceutical technology pioneers in large-molecule targeted drug discovery, where one of the new capabilities (i.e., expertise in biopharmaceutical technology) had higher value added and was more difficult to acquire than other new capabilities.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Publisher Info
Paper provided by DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies in its series DRUID Working Papers with number
08-13.